The antigenic determinants of trichosanthin were predicted by molecular modeling. First, the threedimensional structure model of the antigen-binding fragment of anti-trichosanthin immunoglobulin E was built on the basis of its amino-acid sequence and the known three-dimensional structure of an antibody with similar sequence. Secondly, the preferable antigen-antibody interactions were obtained based on the known three-dimensional structure of trichosanthin and of the hypervariable regions of anti-trichosanthin immunoglobulin E. Two regions in the molecular surface of trichosanthin were found to form extensive interactions with the hypervariable regions of the antibody and have been predicted to be the possible antigenic determinants: one is composed of two polypeptide segments, Ile201-Glu210 and Ile225-Asp229, which are close to each other in the three-dimensional structure; and the other is the segment Lys173-Thr178. The former region seems to be the more reasonable antigenic determinant than the latter one.
INTRODUCTION
Trichosanthin (TCS) is a single-chained ribosome-inactivating protein. It has been used as a traditional Chinese medicine for inducing abortion and the treatment of gynaecological diseases [1, 2] . In recent years, TCS was found to possess anti-HIV activities [3] and has been brought into clinical practice in the U.S.A.. However, TCS is a toxic protein, and the therapeutic effect accompanied with allergic reactions, such as headache and fever, for some patients. Therefore, the prediction of the antigenic determinants of TCS is of importance for the protein engineering in order to reduce the side effects.
The crystallization and three-dimensional structure determination of the complex of TCS with the anti-TCS antibody would be the straightforward method to determine the antigenic determinants of TCS. Immunoglobulin E (IgE) is a class of antibody directly involved in allergic reactions in human body, but it exists in serum at very low concentration. At present stage, there is difficulty in growing the crystals of TCS-IgE complex. In this paper we report the prediction of the antigenic determinants of TCS by molecular modeling.
One of the authors' groups has determined the monoclinic crystal structure of TCS at 2.7 Å resolution [4, 5] , which consists of a large N-terminal domain and a small C-terminal domain containing 181 and 66 amino-acid residues, respectively.
Other group of the authors has succeeded in the cDNA cloning and the gene sequence determination of both the light chains and the heavy chains of five anti-TCS mouse monoclonal IgEs from different fussions [6] . It has been found that all the five IgEs and one monoclonal IgG1 recognize the same site of TCS [7] , suggesting the existence of an allergenic determinant in the surface region of TCS molecule. The amino-acid sequences of both chains have been derived from the gene sequences.
The known structures of all antibodies are very similar to each other. The immunoglobulin is a Y-shaped molecule with two Fab fragment arms and one Fc fragment stem. Each Fab fragment is composed of one constant domain (CL) and one variable domain (VL) from the light chain as well as one constant domain (CH1) and one variable domain (VH) from the heavy chain. CL tightly associates with CH 1 and VL with VH, and a flexible "elbow" connects the two domains of each chain in the Fab fragment [8, 9] . Each variable domain consists of a conserved β-sheet framework and some short loops. Six of the loops, three from the light chain (L1, L2, L3) and three from the heavy chain (H1, H2, H3), vary in length and in amino-acid sequence among different immunoglobulins, which are the hypervariable regions, referred to as complementarity-determining regions (CDRs) and located at the tip of each Fab arm in the Y-shaped antibody molecule. These hypervariable regions are the antigen-binding sites, which recognize different antigens specifically and result in the specific immune responses [10] .
Based on the comparison of known antibody structures and sequences, the "canonical structure model" has been proposed about the conformation of the hypervariable regions of antibodies [11] . In this model, antibodies have only a few main-chain conformations for each hypervariable region, and most sequence variations would only modify the surface provided by the side chains in a canonical main-chain structure. Some experiments [12] even showed that some of the hypervariable regions in the antibodies have the same main-chain conformation in spite of several differences in sequences. However, H3 usually do not comply with the canonical structure model [13] .
METHODS
The first step is to build the three-dimensional structure model of anti-TCS IgE based on the known three-dimensional structures of antibodies and the primary amino-acid sequence of anti-TCS IgE, assuming that the backbone structure of the homologous domains were the same except in the regions where there are length differences between the amino-acid sequences [14] .
One of the five anti-TCS IgEs, TE1, was chosen as the representative of the anti-TCS IgEs since it has been studied more detailed than the others and shows good binding activity with TCS.
There are about thirty antibody fragment structures in Brookhaven Protein Data Bank (PDB, 1993), but none of them contains the variable regions of IgE. The structure of a peptide-complexed Fv fragment of IgG1, B13I2 [15] (PDB entry 2igf) was used as the starting model, which is very similar to TEl in both the length and the sequence (80% identical for the heavy chain and 64% for the light chain). The lengths of CDRs are also quite similar to each other in the two primary structures. In the light chain, CDR1 of TEl is one residue shorter and CDR3 is one residue longer than those in B13I2 while CDR2 has the same length as in the latter. In the heavy chain, the lengths of both CDR1 and CDR2 are the same as in B13I2, but CDR3 are four residues different in length from that in B13I2. This difference probably does not bias our modeling, because unlike the other CDRs the lengths of CDR3 loops of the heavy chains are quite different among the six anti-TCS antibodies while they recognize the same antigen site, suggesting that the length of CDR3 of the heavy chain may not be critical for recognizing the antigenic determinant of TCS.
The primary structure of the starting model was replaced by the amino acid sequence of TE1. Then the model was energy-minimized (500 cycles) to give the three-dimensional structure of the Fv fragment of anti-TCS IgE.
The second step is the prediction of the antigen determinants of TCS by looking for the preferable interactions between TCS and the CDR loops of anti-TCS IgE.
Antigenic determinants are usually located in the surface regions of proteins. We carefully examined all the different surface regions of TCS to look for the regions with the surface roughly complementary to that of the antigen -binding pocket formed by the CDRs of TEl. Then, the sidechain conformation was modified for the residues in these regions of TCS and the corresponding residues in CDRs of TEl to see whether reasonable interactions could be formed (hydrogen bonds, salt bridges and van der Waals contacts were considered). Finally, the surface regions of TCS that can well fit the antigen-binding pocket of TEl were taken as the possible antigenic determinants, and the further adjustment of the side chain conformation and the energy minimization (100 cycles) of the whole structure were performed.
The model building and the manual adjustment were carried out using the graphics software TOM/FRODO [16] and the energy minimization using the program package XPLOR [17] , both on an INDIGO XS24 workstation. The first region is a discontinuous antigenic determinant [18] , composed of two polypeptide segments, Ile201 ~ Glu210 and Ile225 ~ Asp229, which are from different parts of the amino-acid sequence and are brought together by the folding of the polypeptide chain (Fig 2) . The segment Ile201 ~ Glu210 contains two continuous β-turns while the segment Ile225 ~ Asp229 is a β-strand of a hairpin [4] . This region △ is located in the small domain of TCS, with a quite protrusive main-chain conformation in the three-dimensional structure, and the surface of this region is well complementary to that of the hypervariable region of TEl, as shown in Fig 3. Nine of the fifteen residues in this region are polar or charged (Ser, Thr, Asn, Gln and Glu), forming a highly hydrophilic surface. These hydrophilic residues form extensive hydrogen bonds with TEl, which are listed in Tab la. While this region protrudes into the antigen-binding pocket of the antibody, the hydrophobic residues in this region make van der Waals contacts with TEl within 4 Å distances (Tab 2a). The segment Ile201 ~ Glu210 interacts with the CDR loops L3, H2 and H3, and the segment Ile225 ~ Asp229 with L1. The second region is a continuous antigenic determinant [18] , the polypeptide segment Lysl70 Thr178 (Fig 2) , which agrees with the antigenic determinant predicted from the hydrophilicity calculation by CHARGPRO program in PC/GENE [6] . This segment is in the large domain of TCS, and basically consists of a β-turn in the structure [4] . Its main-chain conformation is not so protrusive and the surface is not so complementary to the CDRs of TEl as in region 1 (Fig 4) , but it contains some residues with long and positively charged side-chains, such as Lys173, Arg174 and Lys177, in addition to the polar residues such as Asp176 and Thr178, forming a hydrophilic surface with higher polarity than that in region 1. The extensive hydrogen bonding interactions and van der Waals interactions of this region with TE1 are shown in Tab lb and Tab 2b. Among these residues, Asp176 makes important contribution to the antibody-binding, which form three hydrogen bonds with TE1. The residues from L1, H2 and H3 of TEl are involved in the hydrogen bonding interactions with TCS. From Tab 1 and Tab 2, we can see that CDRH3 of TEl is involved in the interaction with TCS. In our model, Fv model is built upon the sequence of TEl, which has the longest CDRH3 (14 residues) among the six anti-TCS antibodies, and the other CDRH3s have no more than 10 residues. In TE2, the CDRH3 is so short (only 6 residues) that it will not be close enough to TCS in space to form any effective interactions as in the case of TE1. So, we think that the CDRH3s are probably much more related to the affinity of these antibodies than to the recognizing speciality of them.
RESULTS
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DISCUSSION
Molecular modeling, as a method to predict the antigenic determinants, has some substantial uncertainty and limitation. However, it provides a structurally reasonable and energetically favorable model for the design of further experiments.
Here we predict two molecular surface regions of TCS to be the possible antigenic determinants. From the results, we find that the region 1 has a better complementary surface and more extensive interactions with TEl than region 2. Therefore, region 1 seems to be a more reasonable region which can be recognized by these antibodies. However, the experimental evidence is needed to make the conclusion.
The following experimental results support our prediction:
1) The investigation on the sequence conservation and the ELISA determination with the light chain replacement showed that the light chain plays a more important role than the heavy chain in the antigen-binding [6] , which agrees with the results from our modeling study that light chain has a more important role to interact with TCS in region 1 than in region 2.
2) The mutant N227K of TCS showed immune response change (Chen HB, personal communication) and this residue is located in region 1.
